Joellen Welsh Vitamin D

Review

doi: 10.1016/j.jsbmb.2017.07.025. Epub 2017 Jul 23.

Vitamin D and breast cancer: Past and present

Affiliations

PMID: 28746837
PMCID: PMC5780261
DOI: 10.1016/j.jsbmb.2017.07.025

Free PMC article

Review

Vitamin D and breast cancer: Past and present

JoEllen Welsh . J Steroid Biochem Mol Biol. 2018 Mar .

Free PMC article

Abstract

The presence of the vitamin D receptor in mammary gland and breast cancer has been recognized since the early 1980s, and multiple pre-clinical studies have demonstrated that its ligand 1,25D modulates normal mammary gland development and sensitivity to carcinogenesis. Although studies have characterized many 1,25D responsive targets in normal mammary cells and in breast cancers, validation of relevant targets that regulate cell cycle, apoptosis, autophagy and differentiation, particularly in vivo, has been challenging. Vitamin D deficiency is common in breast cancer patients and some evidence suggests that low vitamin D status enhances the risk for disease development or progression. Model systems of carcinogenesis have provided evidence that both VDR expression and 1,25D actions change with transformation but clinical data regarding vitamin D responsiveness of established tumors is limited and inconclusive. Because breast cancer is heterogeneous, analysis of VDR actions in specific molecular subtypes of the disease is necessary to clarify the conflicting data. Genomic, proteomic and metabolomic analyses of in vitro and in vivo model systems is also warranted to comprehensively understand the network of vitamin D regulated pathways in the context of breast cancer heterogeneity.

Keywords: Breast cancer; Mammary gland; VDR; Vitamin D.

Figures

**Figure 1. Model depicting VDR expression during mammary stem cell lineage determination**
Mammary stem cells are capable of asymmetric division which generates daughter stem cells and transit amplifying cells. The transit amplifying cells proliferate slowly and give rise to non-cycling progenitor cells, the earliest cell type in this hierarchy that has been demonstrated to express VDR. This cell population (or a slightly later VDR positive progenitor cell) also expresses CYP24A1. Both basal and luminal cell populations originate from the VDR positive progenitor cell. In the course of basal cell differentiation VDR expression is silenced. During luminal cell differentiation both VDR positive and VDR negative cells arise. Eleven luminal cell populations have been identified based on expression of cytokeratins and hormone receptors (ER, AR, VDR). Five of the eleven luminal cell populations express VDR. Any of the cell populations shown here could theoretically give rise to breast cancer, leading to extraordinary heterogeneity in VDR expression. Schematic is based on data from refs –; see text for additional details.

Cited by 26 articles

Assessment the effect of vitamin D supplementation on plasma vitamin D levels, inflammation, and oxidative stress biomarkers based on vitamin D receptor genetic variation in breast cancer survivors: a protocol for clinical trial.

Kazemian E, Akbari ME, Moradi N, Gharibzadeh S, Amouzegar A, Rozek LS, Mondul AM, Khademolmele M, Zarins KR, Ghodoosi N, Shateri Z, Fallah S, Davoodi SH. Kazemian E, et al. J Health Popul Nutr. 2021 Nov 2;40(1):46. doi: 10.1186/s41043-021-00272-9. J Health Popul Nutr. 2021. PMID: 34727991 Free PMC article.
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.

Kumar S, Freelander A, Lim E. Kumar S, et al. Cancers (Basel). 2021 Oct 3;13(19):4972. doi: 10.3390/cancers13194972. Cancers (Basel). 2021. PMID: 34638457 Free PMC article. Review.
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial.

Jiménez-Cortegana C, Sánchez-Martínez PM, Palazón-Carrión N, Nogales-Fernández E, Henao-Carrasco F, Martín García-Sancho A, Rueda A, Provencio M, de la Cruz-Merino L, Sánchez-Margalet V. Jiménez-Cortegana C, et al. Cancers (Basel). 2021 Sep 15;13(18):4622. doi: 10.3390/cancers13184622. Cancers (Basel). 2021. PMID: 34572849 Free PMC article.
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.

Filip-Psurska B, Psurski M, Anisiewicz A, Libako P, Zbrojewicz E, Maciejewska M, Chodyński M, Kutner A, Wietrzyk J. Filip-Psurska B, et al. Int J Mol Sci. 2021 Mar 9;22(5):2781. doi: 10.3390/ijms22052781. Int J Mol Sci. 2021. PMID: 33803480 Free PMC article.
Probing the Scope and Mechanisms of Calcitriol Actions Using Genetically Modified Mouse Models.

Miao D, Goltzman D. Miao D, et al. JBMR Plus. 2020 Dec 5;5(1):e10434. doi: 10.1002/jbm4.10434. eCollection 2021 Jan. JBMR Plus. 2020. PMID: 33553990 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Joellen Welsh Vitamin D

Source: https://pubmed.ncbi.nlm.nih.gov/28746837/

Joellen Welsh Vitamin D